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neuroepithelium bordering the iris. At 120 hpf, mdkA adopts
the mature pattern of expression, being selectively expressed in
horizontal cells and the germinal marginal zone. In contrast,
expression of mdkB commences between 42 and 48 hpf in the
ventronasal retina. Between 50 and 96 hpf, mdkB expression
expands throughout the differentiating retina in the ganglion
cell layer and the vitread INL. This pattern of expression
persists into adulthood. Following light lesions, mdkB
expression is strongly upregulated, and it expands scleras to
include horizontal cells. These data suggest a role for these
signaling molecules in guiding proliferation and/or differenti-
ation of retinal stem/progenitor cells both during development
and regeneration.
doi:10.1016/j.ydbio.2006.04.103
86
Pten dependence distinguishes hematopoietic stem cells
from leukemia-initiating cells
Omer H. Yilmaz, Riccardo Valdez, David O. Ferguson,
Sean J. Morrison
University of Michigan, Ann Arbor, MI, USA
Recent advances have highlighted extensive phenotypic
and functional similarities between normal stem cells and
cancer stem cells. This raises the question of whether it will
be possible to develop therapies that eliminate cancer stem
cells without eliminating normal stem cells. We addressed
this by examining the effect of deleting the Pten tumor
suppressor. Conditional deletion of Pten in adult hemato-
poietic cells led to myeloproliferative disease within days
and transplantable leukemias within weeks. Pten deletion
also promoted hematopoietic stem cell (HSC) proliferation.
However, this cell autonomously led to HSC depletion,
preventing these cells from stably reconstituting irradiated
mice. In contrast to leukemia-initiating cells, HSCs were
therefore unable to maintain themselves without Pten. These
effects of Pten deficiency were largely mediated by mTor as
they could be inhibited by rapamycin. Rapamycin not only
depleted leukemia-initiating cells but also restored normal
HSC function. Mechanistic differences between the mainte-
nance of normal stem cells and cancer stem cells can thus
be targeted to eliminate cancer stem cells without damaging
normal stem cells.
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Lineage segregation at gastrulation requires precise control
of multiple redundant signaling pathways in time and space.
Mouse embryonic organizing centers secrete molecules that
block or stimulate key pathways such as TGFh, Wnt, and
Nodal. At gastrulation, expression of genes that maintain
pluripotency of the epiblast (and ES cells) declines, allowing
expression of lineage-restricted genes in ectoderm, mesoderm,
and embryonic endoderm. It has recently been demonstrated
that ‘‘stem cell factors’’ such as Sox2, Oct4, and nanog bind
directly and repress the expression of many lineage determina-
tion genes. Canonical Wnt signaling has been suggested to be
crucial to the maintenance of stem cell state and embryos null
for select members of the canonical Wnt signaling pathway are
characterized by an expansion of neural tissue at the expense of
mesoderm. Because they express genes typical of the inner cell
mass and epiblast, ES cells are have been widely employed as a
model system to study signaling cascades in differentiation. In
our ES cell monolayer differentiation scheme, over-expression
of a dominant-negative Tcf-4 protein (blocking canonical Wnt
signaling) lead to decreased proliferation and increased
differentiation of neural precursors. In a similar fashion, over-
expression of nanog caused a large increase in Sox-3-positive
neural precursors. Currently, we are constructing mouse ES cell
lines that will inducibly express the dominant-negative Tcf-4 or
nanog, as well as expressing these factors in human ES cells, to
further explore their role in proliferation and differentiation of
ES cells. Supported by NIH P20 GM069985, NS-039438.
doi:10.1016/j.ydbio.2006.04.105
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